Al Mann Steps Down: What Does It Mean?


We have followed the Mannkind story since the company was dropped by Sanofi and has fallen into somewhat of a downward spiral since then. The company's burgeoning debt load is raising questions about the company's ability to continue and whether or not common equity holders will ultimately find any value in coming quarters.



from Biotech News